Sound Pharma Gets Positive Results from Meniere’s Disease Drug Clinical Trial
Sound Pharmaceuticals' Phase 3 trial of an anti-inflammatory drug for Meniere’s disease showed significant improvements in hearing loss.
Sound Pharmaceuticals' Phase 3 trial of an anti-inflammatory drug for Meniere’s disease showed significant improvements in hearing loss.
Gentamicin is said to reduce the excitability of the vestibular cells in a targeted manner. Researchers have now reexamined 32 Austrian treatment cases between 2012 and 2015 and evaluated the results.
Low Pressure Pulse Generator gets nod for patients with condition in only hearing hear.